Insight Advisors, LLC Iterum Therapeutics PLC Transaction History

Insight Advisors, LLC

  • $351 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$0.54 - $2.29 $18,900 - $80,150
-35,000 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$0.97 - $2.39 $260,445 - $641,715
-268,500 Reduced 88.47%
35,000 $28,000
Q1 2021

May 17, 2021
BUY
$0.97 - $2.73 $294,395 - $828,555
303,500 New
303,500 $373,000

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $12.7M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Insight Advisors, LLC Portfolio

Follow Insight Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email